Volume 19 • Issue 6 March 20, 2019
Pharmadirect Logo News
 

DISCOVER NEW ORILISSA

 

AbbVie is proud to announce that new PrORILISSATM is now available in Canada. To discover more,
CLICK HERE

 

PrEUCRISATM - NOW AVAILABLE TO ORDER

 

Pfizer Canada is pleased to announce the launch and availability of PrEUCRISATM (crisaborole ointment 2%). EUCRISA is available in 60 gram tubes. To access EUCRISA Patient Information,
CLICK HERE



 

TEMPORARY SHORTAGE OF RESTASIS® MULTIDOSE

 

Allergan Inc. would like to inform you that RESTASIS® MultiDose 0.05% Oph Emuls is expected to be on temporary shortage.
READ MORE

 

IMPORTANT INFORMATION - SHORTAGE OF RIFADIN® (rifampin)

 

Sanofi-aventis Canada Inc. would like to inform you that Rifadin® (rifampin) is expected to be on shortage.
READ MORE

PRODUCT AWARENESS

 

PREVENTION AND TREATMENT OF IRON DEFICIENCY

 

READ MORE

 

REMINDER - BEPREVETM IS AVAILABLE FOR ORDER

 

Help treat the itch associated with Allergic Conjunctivitis.
READ MORE

 

RECOMMEND SOOTHETM RESTORE (ADVANCED DRY EYE THERAPY)

 

Dry eye is a prevalent condition that may affect up to 29% of the Canadian population. Patients with dry eye often experience a number of symptoms (burning, irritation, itchiness, etc.) and are more likely to have a relatively thin lipid layer. Recommend SootheTM Restore to your patients – it moisturizes for fast relief, helps restore the lipid layer of tears and helps protect against tear loss.
READ MORE

Classifieds
Classifieds